It is assumed that it leads to the treatment of the intractable disease and the decrease of the side effect because it is possible to attack it by the pinpoint by sniping at the cancer cell etc. and using the ability to kill and wound, and to neutralize the protein that causes the inflammation according to the sickness. The proportion of the antibody drug in the medicine market in the world increases, and there will be a prospect of reaching 30 percent in the future in recent years, too. Our company that had made the antibody steadily caught this machine, searched for seeds of the antibody medicine, achieved the following result, and came after it had established it.

March, 2006 (2006)

A monopolistic right concerning development and manufacturing and sales in all parts of the world of the medicine usage for the treatment of anti-human Osteopontin antibody (2K1) is transferred to Asteras medicine manufacture Ltd.

December, 2006 (2006)

The contract concerning the transfer of the right of manufacturing as the medicine for treatment, development, and sales of the antibody that reacts to the amyloid β thought to be one of the causes of the Alzheimer type acknowledgment syndrome in the peculiarity is concluded for Intellect Neurosciences,Inc. (New York City, the United States).

The development offensive is continued, it will search for new antibody medicine seeds by inquiring into the antibody uniqueness and introducing the new high time technology in the future,